• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化血红蛋白A1c:两种即时检测设备与实验室分析仪性能比较

Haemoglobin A1c: comparing performance of two point of care devices with laboratory analyser.

作者信息

Wan Mohd Zin Ruziana Mona, Ahmad Kamil Zati Iwani, Tuan Soh Tuan Rosidah, Embong Mustaffa, Wan Mohamud Wan Nazaimoon

机构信息

Department of Diabetes & Endocrine, Cardiovascular Diabetes and Nutrition Research Centre, Institute for Medical Research, Jalan Pahang, Kuala Lumpur, 50588, Malaysia.

出版信息

BMC Res Notes. 2013 Dec 18;6:540. doi: 10.1186/1756-0500-6-540.

DOI:10.1186/1756-0500-6-540
PMID:24344903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3878320/
Abstract

BACKGROUND

Measurement of HbA1c has been widely used for long-term monitoring and management of diabetes control. There is increasing use of point-of-care (POC) devices for measuring HbA1c where quicker results would allow immediate clinical management decisions to be made. Therefore, it is important to evaluate and compare the performance of such devices to the reference laboratory method.

FINDINGS

A total of 274 venous blood was collected from normal healthy adults during the community screening programmes. The performance of POC devices, Afinion and Quo-test were compared to central laboratory HPLC method; Adams A1c HA 8160. Both POC devices showed good correlation to HA 8160 with r = 0.94 (p < 0.001) and r = 0.95 (p < 0.001) for Afinion and Quo-test respectively. The means difference were statistically higher between POC and HA 8160 with 0.23% (95% CI 0.19-0.26, p < 0.001) and 0.29% (95% CI 0.24-0.34, p < 0.001) for Afinion and Quo-test respectively.

CONCLUSIONS

Both POC devices could be considered in health clinics for diabetes management but not to be used for the diagnostic purposes.

摘要

背景

糖化血红蛋白(HbA1c)的测定已广泛用于糖尿病控制的长期监测和管理。即时检测(POC)设备在测定HbA1c方面的应用越来越多,其更快的检测结果能够使临床医生立即做出管理决策。因此,评估和比较此类设备与参考实验室方法的性能很重要。

研究结果

在社区筛查项目期间,共从正常健康成年人中采集了274份静脉血样。将POC设备Afinion和Quo-test的性能与中心实验室的高效液相色谱法(HPLC)——Adams A1c HA 8160进行了比较。两种POC设备与HA 8160均显示出良好的相关性,Afinion和Quo-test的相关系数r分别为0.94(p < 0.001)和0.95(p < 0.001)。POC设备与HA 8160之间的平均差异具有统计学意义,Afinion和Quo-test分别为0.23%(95%置信区间0.19 - 0.26,p < 0.001)和0.29%(95%置信区间0.24 - 0.34,p < 0.001)。

结论

在健康诊所进行糖尿病管理时可以考虑使用这两种POC设备,但不能用于诊断目的。

相似文献

1
Haemoglobin A1c: comparing performance of two point of care devices with laboratory analyser.糖化血红蛋白A1c:两种即时检测设备与实验室分析仪性能比较
BMC Res Notes. 2013 Dec 18;6:540. doi: 10.1186/1756-0500-6-540.
2
Good correlation between the Afinion AS100 analyser and the ABX Pentra 400 analyser for the measurement of glycosylated haemoglobin and lipid levels in older adults in Durban, South Africa.在南非德班的老年人中,Afinion AS100分析仪与ABX Pentra 400分析仪在糖化血红蛋白和血脂水平测量方面具有良好的相关性。
S Afr Med J. 2017 Dec 13;108(1):50-55. doi: 10.7196/SAMJ.2017.v108i1.12548.
3
Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.Axis-Shield Afinion糖化血红蛋白测量设备的准确性和精密度。
J Diabetes Sci Technol. 2012 Mar 1;6(2):380-6. doi: 10.1177/193229681200600224.
4
Evaluation of Three Hemoglobin A1c Point-of-Care Instruments.三种糖化血红蛋白即时检测仪器的评估
Clin Lab. 2016;62(3):285-91. doi: 10.7754/clin.lab.2015.150301.
5
Evaluation of two HbA1c point-of-care analyzers.两种即时 HbA1c 分析仪的评估。
Clin Chem Lab Med. 2011 Apr;49(4):653-7. doi: 10.1515/CCLM.2011.101. Epub 2011 Feb 17.
6
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.评估两款在秘鲁亚马逊地区用于测量血红蛋白 A1c 的即时血糖仪。
Ann Glob Health. 2018 Nov 5;84(4):618-624. doi: 10.9204/aogh.2368.
7
Verification of a novel point-of-care HbA device in real world clinical practice by comparison to three high performance liquid chromatography instruments.通过与三种高效液相色谱仪器比较,对新型即时 HbA 检测设备进行真实世界临床实践验证。
Biochem Med (Zagreb). 2018 Jun 15;28(2):020705. doi: 10.11613/BM.2018.020705. Epub 2018 Apr 15.
8
Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method.糖化血红蛋白 A1c:三种即时检测分析仪与中心实验室方法的评估比较。
Clin Chim Acta. 2010 Dec 14;411(23-24):2062-6. doi: 10.1016/j.cca.2010.09.004. Epub 2010 Sep 8.
9
Multicenter assessment of a hemoglobin A1c point-of-care device for diagnosis of diabetes mellitus.用于糖尿病诊断的糖化血红蛋白即时检测设备的多中心评估。
Clin Biochem. 2018 Nov;61:18-22. doi: 10.1016/j.clinbiochem.2018.09.007. Epub 2018 Sep 17.
10
Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).临床实践中的糖化血红蛋白评估:A1cNow即时检验设备与中心实验室检测的比较(糖化血红蛋白目标研究)
Diabetes Technol Ther. 2005 Dec;7(6):907-12. doi: 10.1089/dia.2005.7.907.

引用本文的文献

1
Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.评估两款在秘鲁亚马逊地区用于测量血红蛋白 A1c 的即时血糖仪。
Ann Glob Health. 2018 Nov 5;84(4):618-624. doi: 10.9204/aogh.2368.
2
External Quality Assessment of Glycated Hemoglobin in Iran: Comparison of Five Different Commercial Methods with Two Different Total Allowable Errors.伊朗糖化血红蛋白的外部质量评估:五种不同商业方法与两种不同总允许误差的比较
J Med Biochem. 2018 Dec 1;37(4):397-405. doi: 10.1515/jomb-2017-0057. eCollection 2018 Dec.

本文引用的文献

1
Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion.马来西亚的糖尿病患病率及 HbA1c 作为诊断标准的实用性。
Diabet Med. 2013 Jul;30(7):825-8. doi: 10.1111/dme.12161. Epub 2013 Mar 23.
2
Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.Axis-Shield Afinion糖化血红蛋白测量设备的准确性和精密度。
J Diabetes Sci Technol. 2012 Mar 1;6(2):380-6. doi: 10.1177/193229681200600224.
3
Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006.
2006年马来西亚第三次全国健康与发病率调查中的糖尿病患病率。
Med J Malaysia. 2010 Sep;65(3):180-6.
4
Evaluation of two HbA1c point-of-care analyzers.两种即时 HbA1c 分析仪的评估。
Clin Chem Lab Med. 2011 Apr;49(4):653-7. doi: 10.1515/CCLM.2011.101. Epub 2011 Feb 17.
5
Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method.糖化血红蛋白 A1c:三种即时检测分析仪与中心实验室方法的评估比较。
Clin Chim Acta. 2010 Dec 14;411(23-24):2062-6. doi: 10.1016/j.cca.2010.09.004. Epub 2010 Sep 8.
6
Evaluation of the Quo-Test hemoglobin A1c point-of-care instrument: second chance.Quo-Test糖化血红蛋白即时检测仪器的评估:再次尝试。
Clin Chem. 2010 Jul;56(7):1191-3. doi: 10.1373/clinchem.2010.143149. Epub 2010 Apr 29.
7
Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria.八种血红蛋白 A1c 即时检测仪器中有六种不符合普遍接受的分析性能标准。
Clin Chem. 2010 Jan;56(1):44-52. doi: 10.1373/clinchem.2009.130641. Epub 2009 Nov 19.
8
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.国际专家委员会关于糖化血红蛋白检测在糖尿病诊断中作用的报告。
Diabetes Care. 2009 Jul;32(7):1327-34. doi: 10.2337/dc09-9033. Epub 2009 Jun 5.
9
Results of an innovative education, training and quality assurance program for point-of-care HbA1c testing using the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health Services.在澳大利亚原住民社区控制卫生服务机构中,使用拜耳DCA 2000进行即时糖化血红蛋白(HbA1c)检测的创新教育、培训及质量保证项目的结果
Clin Biochem Rev. 2003 Nov;24(4):123-30.
10
Desirable performance standards for HbA(1c) analysis - precision, accuracy and standardisation: consensus statement of the Australasian Association of Clinical Biochemists (AACB), the Australian Diabetes Society (ADS), the Royal College of Pathologists of Australasia (RCPA), Endocrine Society of Australia (ESA), and the Australian Diabetes Educators Association (ADEA).糖化血红蛋白(HbA(1c))分析的理想性能标准——精密度、准确度和标准化:澳大利亚临床生物化学家协会(AACB)、澳大利亚糖尿病协会(ADS)、澳大利亚皇家病理学家学会(RCPA)、澳大利亚内分泌学会(ESA)以及澳大利亚糖尿病教育者协会(ADEA)的共识声明
Clin Chem Lab Med. 2007;45(8):1083-97. doi: 10.1515/CCLM.2007.158.